Literature DB >> 8398142

The ability of agrin to cluster AChRs depends on alternative splicing and on cell surface proteoglycans.

M J Ferns1, J T Campanelli, W Hoch, R H Scheller, Z Hall.   

Abstract

Agrin, which induces acetylcholine receptor (AChR) clustering at the developing neuromuscular synapse, occurs in multiple forms generated by alternative splicing. Some of these isoforms are specific to the nervous system; others are expressed in both neural and nonneural tissues, including muscle. We have compared the AChR clustering activity of agrin forms varying at each of the three identified splicing sites, denoted x, y, and z. Agrin isoforms were assayed by applying either transfected COS cells, with agrin bound to their surfaces, or soluble agrin to myotubes of the C2 muscle line, or of two variant lines having defective proteoglycans. Dramatic differences in activity were seen between z site isoforms and lesser differences between y site isoforms. The most active agrin forms contained splicing inserts of 4 amino acids at the y site and 8 amino acids at the z site. These forms are found exclusively in neural tissue. All forms were active on C2 myotubes in cell-attached assays, but muscle forms were less active than neural forms. AChR clustering activity of all agrin forms was decreased when assayed on the proteoglycan-deficient lines, suggesting that proteoglycans may help mediate the action of agrin. As neural agrin forms are more active than muscle forms, they are likely to play a primary role in synaptogenesis.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8398142     DOI: 10.1016/0896-6273(93)90153-i

Source DB:  PubMed          Journal:  Neuron        ISSN: 0896-6273            Impact factor:   17.173


  91 in total

1.  Roles of rapsyn and agrin in interaction of postsynaptic proteins with acetylcholine receptors.

Authors:  C Fuhrer; M Gautam; J E Sugiyama; Z W Hall
Journal:  J Neurosci       Date:  1999-08-01       Impact factor: 6.167

2.  Schwann cells express active agrin and enhance aggregation of acetylcholine receptors on muscle fibers.

Authors:  J F Yang; G Cao; S Koirala; L V Reddy; C P Ko
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

3.  Synapse-forming axons and recombinant agrin induce microprocess formation on myotubes.

Authors:  C S Uhm; B Neuhuber; B Lowe; V Crocker; M P Daniels
Journal:  J Neurosci       Date:  2001-12-15       Impact factor: 6.167

4.  Src-class kinases act within the agrin/MuSK pathway to regulate acetylcholine receptor phosphorylation, cytoskeletal anchoring, and clustering.

Authors:  A S Mohamed; K A Rivas-Plata; J R Kraas; S M Saleh; S L Swope
Journal:  J Neurosci       Date:  2001-06-01       Impact factor: 6.167

5.  Alternative splicing of agrin regulates its binding to heparin alpha-dystroglycan, and the cell surface.

Authors:  J J O'Toole; K A Deyst; M A Bowe; M A Nastuk; B A McKechnie; J R Fallon
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-09       Impact factor: 11.205

6.  Agrin is a major heparan sulfate proteoglycan accumulating in Alzheimer's disease brain.

Authors:  M M Verbeek; I Otte-Höller; J van den Born; L P van den Heuvel; G David; P Wesseling; R M de Waal
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

7.  Agrin induced morphological and structural changes in growth cones of cultured hippocampal neurons.

Authors:  R A Bergstrom; R C Sinjoanu; A Ferreira
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

8.  LRP4 serves as a coreceptor of agrin.

Authors:  Bin Zhang; Shiwen Luo; Qiang Wang; Tatsuo Suzuki; Wen C Xiong; Lin Mei
Journal:  Neuron       Date:  2008-10-23       Impact factor: 17.173

9.  Specific agrin isoforms induce cAMP response element binding protein phosphorylation in hippocampal neurons.

Authors:  R R Ji; C M Böse; C Lesuisse; D Qiu; J C Huang; Q Zhang; F Rupp
Journal:  J Neurosci       Date:  1998-12-01       Impact factor: 6.167

Review 10.  The role of muscle-specific tyrosine kinase (MuSK) and mystery of MuSK myasthenia gravis.

Authors:  Inga Koneczny; Judith Cossins; Angela Vincent
Journal:  J Anat       Date:  2013-03-04       Impact factor: 2.610

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.